Nirmatrelvir-ritonavir significantly reduced the risk for severe COVID-19 outcomes among nonhospitalized patients, highlighting the importance of early antiviral treatment particularly in aging and ...

This important study used five metrics to compare the cost-effectiveness of intramural and extramural research funded by the National Institutes of Health in the United States between 2009 and 2019.